Contract analysis
Clause-by-clause risk read on any document of the firm. Pick a contract, or open any document from a matter.
Contract analysis / closing-funds-flow-memorandum.xlsx
closing-funds-flow-memorandum.xlsx
High · 1
Medium · 0
Standard · 0
[sheet: Cover]
High
⚑ Indemnity / guarantee obligation
[sheet: Cover] Field | Value Document Title | Closing Funds Flow Memorandum Transaction | Asset Purchase of OncuPath™ Companion Diagnostics Assay Line Seller | Genome Dx Therapeutics Inc. (EIN: 47-3892061) Buyer | Meridian Precision Diagnostics, Inc. (EIN: 56-4210783) Closing Date | August 8, 2023 Total Consideration | $140,000,000 Closing Cash Payment | $126,000,000 Earnout (Maximum) | $14,000,000 (not funded at clo